Randomized, Blinded Phase III Trial Comparing Calendula Officinalis Cream With Standard Aqueous Cream "Essex" for Treatment of Skin Reactions Caused by Postoperative Radiotherapy of Breast Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Grade of skin reactions to radiotherapy
Skin reactions due to radiotherapy using RTOG scale
8 weeks
No
Maria AC Bergenmar, PhD
Principal Investigator
Dept of Oncology, Karolinska University Hospital, Stockholm, Sweden
Sweden: Medical Products Agency
Calendula trial
NCT01688479
February 2011
September 2012
Name | Location |
---|